Part II: Dermatologic manifestations associated with treatment of patients with kidney disease
Journal of the American Academy of Dermatology · 2026
DOI: 10.1016/j.jaad.2025.06.034 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Academy of Dermatology, 2026. Verfasst von Amit Singal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers New Jersey Medical School, Newark, New Jersey. Hauptthemen laut MEDLINE: Kidney Failure, Chronic, Renal Dialysis, Skin Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 120 Literaturangaben.
Abstract (Originalsprache)
Dermatologists are instrumental in diagnosing and treating dermatologic manifestations of end-stage kidney disease (ESKD), and affected patients require a multidisciplinary team-based approach to management. In part 2 of this two-part continuing medical education series, we review dermatologic manifestations associated with the management and therapeutics of ESKD. Herein, we highlight the epidemiology, clinical presentation, and management of unique treatment-associated dermatoses in patients with ESKD, including calciphylaxis, dialysis-related amyloidosis, access steal syndrome, acroangiodermatitis, and nephrogenic systemic fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rutgers New Jersey Medical School, Newark, New Jersey.
- Departments of Dermatology and Pathology, Yale University School of Medicine, New Haven, Connecticut.
- Departments of Dermatology and Pathology, Duke University School of Medicine, Durham, North Carolina.
- Division of Nephrology, Maimonides Medical Center, Brooklyn, New York.
- Department of Dermatology and Department of Pathology and Laboratory Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.
Zitieren
APA
Singal, A., Cowper, S. E., Ko, C. J., Kroshinsky, D., Lipner, H. I., Robinson-Bostom, L., Yosipovitch, G., & Lipner, S. R. (2026). Part II: Dermatologic manifestations associated with treatment of patients with kidney disease. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2025.06.034
Vancouver
Singal A, Cowper SE, Ko CJ, Kroshinsky D, Lipner HI, Robinson-Bostom L, et al. Part II: Dermatologic manifestations associated with treatment of patients with kidney disease. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2025.06.034
BibTeX
@article{Singal2026,
author = {Singal, Amit and Cowper, Shawn E and Ko, Christine J and Kroshinsky, Daniela and Lipner, Henry I and Robinson-Bostom, Leslie and Yosipovitch, Gil and Lipner, Shari R},
title = {Part II: Dermatologic manifestations associated with treatment of patients with kidney disease},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2025.06.034}
}
EUVIMED